Controveries in Urologic Cancer

>

Latest News

Controversies in Urologic Cancer
Controversies in Urologic Cancer

April 27th 2018

How can you be sure you’ve selected the best approach for your patients with urologic cancer? As our experts debate developments like MRI fusion biopsy for PCa, HIFU for low-risk prostate cancer, and white light cystoscopy, learn how you can integrate these treatments into your practice.

Point: Is MRI fusion biopsy the new gold standard for diagnosis?

April 10th 2018

Counterpoint: Is MRI fusion biopsy the new gold standard for diagnosis?

April 9th 2018

Point: Is HIFU for low-risk prostate Ca ready for prime time?

April 8th 2018

Counterpoint: Is HIFU for low-risk prostate Ca ready for prime time?

April 7th 2018

More News

© 2024 MJH Life Sciences

All rights reserved.